historical

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Travelzoo META Opens for Founding Members

Source Node:
Time Stamp: May 11, 2023 7:21 AM - Modified On: May 11, 2023 - Published By:
Source Cluster:
Republished By Plato

NEW YORK/PARIS/TOKYO, May 11, 2023 - (ACN Newswire) - The future of travel is here. After months of anticipation, Travelzoo META, a members-only service offering groundbreaking Metaverse travel experiences, is now accepting its first one million Founding Members. Launched by Travelzoo® (NASDAQ: TZOO), a global Internet media company, Travelzoo META will give Founding Members the opportunity to be the first to experience travel in the Metaverse. Travelzoo META's experiences are intended to allow its members to explore hard-to-reach corners of the world, like summiting Mount Everest, or travel back in time—to

Old Gold is the New Gold when Music Meets NFTs

Source Node:
Time Stamp: November 18, 2022 3:06 AM - Modified On: November 18, 2022 - Published By:
Source Cluster:
Republished By Plato

“Old is Gold” is the result of a collaboration of Authentic Heroes Inc., marrying the music of Maestro Entertainment Corp. with the distribution and manufacturing prowess of Inventel,Inc. with the platform powered by the block chain experts at https://macnerd.io November 25th,  2022 sees the arrival exclusively in retail stores of a new generation of music distribution, the pairing of vinyl records and NFTs. The Gold Album for this year’s Christmas “Must Have” is the “Old is Gold” vinyl Christmas Album. A priceless, timeless collection of the Christmas tunes we know

Meet Spectre: The Platform Revolutionizing and Simplifying High Frequency Trading

Source Node:
Time Stamp: September 27, 2022 8:22 AM - Modified On: September 27, 2022 - Published By:
Source Cluster:
Republished By Plato

By Plato Blockchain When first stumbling into the world of high frequency trading, the complicated jargon and unintuitive platforms are oftentimes a barrier for non-technical users to understand their workings. Luckily, with the increase in interest in blockchain technology around the world coupled with human nature to innovate, development teams around the world are creating platforms for novice and experienced users alike to trade cryptocurrencies in a simple manner. A web search for “best trading platform” yields nearly 383 million results. Yet, after diving into some of these results, one

Legacy Block (BLCK:Pancakeswap) partners with Power of One Foundation to end hunger.

Source Node:
Time Stamp: February 28, 2022 1:01 AM - Modified On: February 28, 2022 - Published By:
Source Cluster:
Republished By Plato

Santa Ana  Mayor Vincent Sarmeinto giving Andre Roberson CEO Power of One the Key to the City. Santa Ana, CA - (PLATO) - February 28, 2022 - Power of One Foundation (“POOF”) has entered into a partnership with Legacy Block (BLCK:Pancakeswap). BLCK is an operating  division of Peerless Exponential Partners, LLC (PXP). By way of the partnership  POOF will use Legacy Block’s BLCK governance token as the governance token for a series of new blockchain based projects targeted at ending hunger in the United States.  These projects will materially increase